Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Chief Technology Officer | Kelly Timothy P | Feb 25, 2026 | Sell | $12.02K | 6,228 |
| Chief Business Officer | Khan Ruhi Ahmad | Feb 24, 2026 | Sell | $13.6K | 6,938 |
| Chief Technology Officer | Kelly Timothy P | Feb 24, 2026 | Sell | $6.17K | 3,147 |
| Chief Medical Officer | Albertson Tina M. | Feb 24, 2026 | Sell | $2.09K | 1,066 |
| Chief Legal Officer | MCCLUNG BARBARA G | Feb 24, 2026 | Sell | $13.6K | 6,938 |
| CEO | Haurwitz Rachel E. | Mar 14, 2025 | Buy | $20.4K | 20,000 |
| Chief Business Officer | Khan Ruhi Ahmad | Feb 21, 2025 | Sell | $4.81K | 3,564 |
| Chief Scientific Officer | Kanner Steven | Feb 21, 2025 | Sell | $4.81K | 3,564 |
| Chief Legal Officer | MCCLUNG BARBARA G | Feb 21, 2025 | Sell | $4.81K | 3,564 |
| CFO | Ryali Sriram | Jan 29, 2025 | Buy | $24.65K | 17,360 |
| Chief Medical Officer | Rizvi Syed Ali-aamir | Jan 19, 2023 | Sell | $35.51K | 5,627 |
| VP of Finance and Controller | Fischesser Ryan | Oct 6, 2022 | Sell | $107.96K | 10,000 |
| Chief Scientific Officer | Kanner Steven | Aug 25, 2022 | Sell | $485.22K | 43,248 |
| VP of Finance and Controller | Fischesser Ryan | Jan 11, 2022 | Buy | $1.53K | 569 |
| VP of Finance and Controller | Fischesser Ryan | Jan 11, 2022 | Buy | $28.02K | 6,818 |
| VP of Finance and Controller | Fischesser Ryan | Dec 20, 2021 | Buy | $3.06K | 1,136 |
| Chief Legal Officer | MCCLUNG BARBARA G | Dec 7, 2021 | Buy | $32.28 | 12 |
| Chief Legal Officer | MCCLUNG BARBARA G | Dec 7, 2021 | Buy | $16.45K | 6,115 |
| Chief Legal Officer | MCCLUNG BARBARA G | Oct 20, 2021 | Buy | $24.68K | 9,176 |
| Chief Legal Officer | MCCLUNG BARBARA G | Oct 20, 2021 | Buy | $115.67 | 43 |
| Chief Scientific Officer | Kanner Steven | Oct 12, 2021 | Buy | $180.18K | 99,548 |
| Chief Scientific Officer | Kanner Steven | Oct 12, 2021 | Buy | $1.26K | 698 |
| Chief Scientific Officer | Kanner Steven | Oct 12, 2021 | Buy | $39.31K | 14,614 |
| VP of Finance and Controller | Fischesser Ryan | Oct 11, 2021 | Buy | $4.7K | 1,746 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.